In the past years, treatment options for advanced hepatocellular carcinoma (HCC) have
thriven. Although globally recognised, the patient‐reported outcomes (PROs) are often …

Patient-reported outcomes (PROs) are a powerful tool for oncology care. PROs are defined
as information about a patientLs health that comes directly from the patient and can include …

Patients with cancer experience many physical and psychological symptoms that negatively
impact both their experience of their illness and health outcomes (1–4). Among patients with …

476 Background: Atezo+ bev in pts with unresectable HCC who had not received prior
systemic therapy has shown statistically significant and clinically meaningful improvement in …

Health-related quality of life has become an important aspect in oncologic decision making.
Recent data suggest that Health-Related Quality of Life (HRQoL) measurements can play an …

Purpose Clinical trials in oncology evaluating the effects of patient-reported outcomes (PRO)
collection have found that monitoring of symptoms with PROs is associated with improved …

Methods| The study was approved by the Memorial Sloan Kettering institutional review
board and written informed consent was obtained from participants. Consecutive patients …

Background Trans-hepatic arterial chemoembolization (TACE) is a treatment option for liver
cancer patients. It can prolong patients' survival but can also cause symptom distress …

Although there are several established international guidelines on the management of
hepatocellular carcinoma (HCC), there is limited information detailing specific indicators of …

Aim: The purpose of the study was to determine the feasibility and validity of using health‐
related quality of life (HRQL) and patient benefit as outcome measures in a phase II trial of …